Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
04:37

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications

Published on: June 16, 2023

1.8K

Hybrid approach in hypoplastic left heart syndrome

Dietmar Schranz

    Heart (British Cardiac Society)
    |February 4, 2014
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    Allied Specialities

    More Related Videos

    Implantation of Total Artificial Heart in Congenital Heart Disease
    07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    28.4K
    Novel and Innovative Hybrid Technique for Type A Aortic Dissection
    06:26

    Novel and Innovative Hybrid Technique for Type A Aortic Dissection

    Published on: March 28, 2025

    1.4K

    Related Experiment Videos

    Last Updated: May 3, 2026

    Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
    04:37

    Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications

    Published on: June 16, 2023

    1.8K
    Implantation of Total Artificial Heart in Congenital Heart Disease
    07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    28.4K
    Novel and Innovative Hybrid Technique for Type A Aortic Dissection
    06:26

    Novel and Innovative Hybrid Technique for Type A Aortic Dissection

    Published on: March 28, 2025

    1.4K

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    805
    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    805
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    753
    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    753

    Articles linked to this work by shared authors, journal, and citation graph.

    Reverse Remodeling in Pediatric Myocarditis With DCM Phenotype Impact of rASD and PAB.

    JACC. Advances·2026

    Percutaneous Deployment of the Sinus-SuperFlex-DS Stent for Hybrid Stage I Palliation in Neonates Weighing ≤ 2.5 kg: A Multicenter Study.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

    Proposal: Bold New Indications for Transcatheter Pulmonary Flow Restrictors.

    Pediatric cardiology·2025

    Aspirin in Children; are There Not Two Sides of the Same Coin?

    Pediatric cardiology·2024

    Perioperative anesthetic management of patients with hypoplastic left heart syndrome undergoing the comprehensive stage II surgery-A review of 148 cases.

    Paediatric anaesthesia·2024

    A Global Perspective on PDA Management in the Extremely Premature: Shifting Trend Toward Transcatheter Closure.

    Journal of the Society for Cardiovascular Angiography & Interventions·2024

    Valvular involvement, phenotypic heterogeneity and outcomes in adults with left-to-right shunt congenital heart disease.

    Heart (British Cardiac Society)·2026

    NT-proBNP in relation to clinical characteristics and cardiovascular outcomes in non-anticoagulated patients with atrial fibrillation.

    Heart (British Cardiac Society)·2026

    Coronary calcium scoring in the evaluation of stable chest pain in general practice: a cluster-randomised trial.

    Heart (British Cardiac Society)·2026

    Haemodynamic response to exercise in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction.

    Heart (British Cardiac Society)·2026

    Bidirectional links between heart failure and cancer: shared pathophysiology, clinical outcomes and collaborative management.

    Heart (British Cardiac Society)·2026

    Sudden cardiac death risk after myocardial infarction across the spectrum of left ventricular ejection fraction: a meta-analysis.

    Heart (British Cardiac Society)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us